teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - sclerosi multipla recidivante-remittente - immunosoppressori - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - sclerosi multipla recidivante-remittente - immunosoppressori selettivi immunosoppressori - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
teriflunomide teva
teva b.v. - teriflunomide - teriflunomide
teriflunomide medac
medac pharma srl - teriflunomide - teriflunomide
teriflunomide zentiva
zentiva italia s.r.l. - teriflunomide - teriflunomide
teriflunomide dr. reddy's
dr. reddy's s.r.l. - teriflunomide - teriflunomide
teriflunomide eg
eg s.p.a. - teriflunomide - teriflunomide
teriflunomide hcs
hcs bv - teriflunomide - teriflunomide
teriflunomide medical valley
medical valley invest ab - teriflunomide - teriflunomide
teriflunomide abdi
abdi farma gmbh - teriflunomide - teriflunomide